446 related articles for article (PubMed ID: 19440556)
1. Clinical trial design for adenoviral gene therapy products.
Shirakawa T
Drug News Perspect; 2009 Apr; 22(3):140-5. PubMed ID: 19440556
[TBL] [Abstract][Full Text] [Related]
2. Adenoviral strategies for the gene therapy of cancer.
Relph KL; Harrington KJ; Pandha H
Semin Oncol; 2005 Dec; 32(6):573-82. PubMed ID: 16338423
[TBL] [Abstract][Full Text] [Related]
3. [Adenovirus vectors and their clinical application in gene therapy].
Adám E; Nász I
Orv Hetil; 2001 Sep; 142(38):2061-70. PubMed ID: 11697063
[TBL] [Abstract][Full Text] [Related]
4. Clinical experience with adenovirus in cancer therapy.
Palmer DH; Mautner V; Kerr DJ
Curr Opin Mol Ther; 2002 Oct; 4(5):423-34. PubMed ID: 12435043
[TBL] [Abstract][Full Text] [Related]
5. Adenoviral gene therapy for cancer: from vectors to targeted and replication competent agents (review).
Bauerschmitz GJ; Barker SD; Hemminki A
Int J Oncol; 2002 Dec; 21(6):1161-74. PubMed ID: 12429964
[TBL] [Abstract][Full Text] [Related]
6. The controversial role of adenoviral-derived vectors in gene therapy programs: where do we stand?
Romano G
Drug News Perspect; 2006 Mar; 19(2):99-106. PubMed ID: 16628265
[TBL] [Abstract][Full Text] [Related]
7. Adenoviral vectors: systemic delivery and tumor targeting.
Green NK; Seymour LW
Cancer Gene Ther; 2002 Dec; 9(12):1036-42. PubMed ID: 12522442
[TBL] [Abstract][Full Text] [Related]
8. [Gene therapy and molecular therapeutic for head and neck cancer].
Tanaka H
Gan To Kagaku Ryoho; 2005 Dec; 32(13):2046-51. PubMed ID: 16352927
[TBL] [Abstract][Full Text] [Related]
9. Tech.Sight. Gene therapy. Hurdles and hopes for cancer treatment.
Hunt KK; Vorburger SA
Science; 2002 Jul; 297(5580):415-6. PubMed ID: 12130788
[TBL] [Abstract][Full Text] [Related]
10. [Conditionally replicative adenoviruses: a second wind for cancer gene therapy].
Grill J; Geoerger B; Lamfers M; Dirven C; Van Beusechem V; Gerritsen W; Vassal G
Bull Cancer; 2003 Dec; 90(12):1039-48. PubMed ID: 14715423
[TBL] [Abstract][Full Text] [Related]
11. Clinical research results with dl1520 (Onyx-015), a replication-selective adenovirus for the treatment of cancer: what have we learned?
Kirn D
Gene Ther; 2001 Jan; 8(2):89-98. PubMed ID: 11313778
[TBL] [Abstract][Full Text] [Related]
12. Adenoviral p53 gene therapy in squamous cell cancer of the head and neck region.
Edelman J; Edelman J; Nemunaitis J
Curr Opin Mol Ther; 2003 Dec; 5(6):611-7. PubMed ID: 14755887
[TBL] [Abstract][Full Text] [Related]
13. Human adenovirus type 35 vector for gene therapy of brain cancer: improved transduction and bypass of pre-existing anti-vector immunity in cancer patients.
Brouwer E; Havenga MJ; Ophorst O; de Leeuw B; Gijsbers L; Gillissen G; Hoeben RC; ter Horst M; Nanda D; Dirven C; Avezaat CJ; Goudsmit J; Sillevis Smitt P
Cancer Gene Ther; 2007 Feb; 14(2):211-9. PubMed ID: 17082793
[TBL] [Abstract][Full Text] [Related]
14. Adenoviral vectors--how to use them in cancer gene therapy?
Majhen D; Ambriović-Ristov A
Virus Res; 2006 Aug; 119(2):121-33. PubMed ID: 16533542
[TBL] [Abstract][Full Text] [Related]
15. Conditionally replicative adenoviral vectors for malignant glioma.
Sonabend AM; Ulasov IV; Lesniak MS
Rev Med Virol; 2006; 16(2):99-115. PubMed ID: 16416455
[TBL] [Abstract][Full Text] [Related]
16. The potential of oncolytic virus therapy for pancreatic cancer.
Kasuya H; Takeda S; Nomoto S; Nakao A
Cancer Gene Ther; 2005 Sep; 12(9):725-36. PubMed ID: 15818382
[TBL] [Abstract][Full Text] [Related]
17. Adenoviral gene therapy for pancreatic cancer: where do we stand?
Kuhlmann KF; Gouma DJ; Wesseling JG
Dig Surg; 2008; 25(4):278-92. PubMed ID: 18635930
[TBL] [Abstract][Full Text] [Related]
18. Gene therapy: a molecular approach to cancer treatment.
Anklesaria P
Curr Opin Mol Ther; 2000 Aug; 2(4):426-32. PubMed ID: 11249773
[TBL] [Abstract][Full Text] [Related]
19. Gene therapy for malignant glioma: current clinical status.
Pulkkanen KJ; Yla-Herttuala S
Mol Ther; 2005 Oct; 12(4):585-98. PubMed ID: 16095972
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic potential of adenoviral vectors for delivery of expressed RNAi activators.
Mowa MB; Crowther C; Arbuthnot P
Expert Opin Drug Deliv; 2010 Dec; 7(12):1373-85. PubMed ID: 21073358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
